Peter Sayre, MD, Oncology, San Francisco, CA, UCSF Medical Center

PeterH.SayreMD

Oncology San Francisco, CA

Hematologic Oncology

Professor, Diabetes Center, UCSF School of Medicine

Dr. Sayre is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sayre's full profile

Already have an account?

Education & Training

  • University of California San Diego
    University of California San DiegoResidency, Internal Medicine, 1990 - 1993
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1992 - 2021
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Journal Articles

  • Prevalence and Impact of De Novo DSA During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients  
    Sandy Feng, Josh Levitsky, Peter Sayre, Matthew J Everly, Abraham Shaked, Hepatology

Abstracts/Posters

  • Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart¬ Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
    Peter H. Sayre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Stallergenes Greer Investit Dans Adeo Health Science, Entreprise Spécialisée Dans La Recherche Alimentaire, Avec Une Approche Novatrice Pour Les Allergies Alimentaires
    Stallergenes Greer Investit Dans Adeo Health Science, Entreprise Spécialisée Dans La Recherche Alimentaire, Avec Une Approche Novatrice Pour Les Allergies AlimentairesOctober 25th, 2017
  • Stallergenes Greer Invests in Adeo Health Science, a Research-Driven Food Company with a Novel Approach in Food Allergy
    Stallergenes Greer Invests in Adeo Health Science, a Research-Driven Food Company with a Novel Approach in Food AllergyOctober 25th, 2017
  • Childhood Peanut Allergy (Pedcast)
    Childhood Peanut Allergy (Pedcast)January 25th, 2016
  • Join now to see all

Hospital Affiliations